Abstracts Archive - Page 1048 of 2425 - ACR Meeting Abstracts

Abstract Number: 651 • 2018 ACR/ARHP Annual Meeting
Analysis of the Different Value of Magnetic Resonance Imaging Changes in the Sacroiliac Joints for a Diagnosis of Axial Spondyloarthritis As Judged By Rheumatologists and Radiologists
Xenofon Baraliakos¹, Ana Ghadir², Martin Fruth², Uta Kiltz³ and Jürgen Braun¹, ¹Ruhr-University Bochum, Herne, Germany, ²Rheumazentrum Ruhrgebiet, Herne, Germany, ³Rheumatology, Rheumazentrum Ruhrgebiet, Herne, and Ruhr University Bochum, Herne, Germany
Background/Purpose: Classification of axial spondyloarthritis (axSpA) by the imaging arm of the ASAS criteria relies partly on the detection of a bone marrow edema (BME)…
Abstract Number: 652 • 2018 ACR/ARHP Annual Meeting
Disease Interception in Psoriasis Patients with Subclinical Joint Inflammation By Interleukin 17 Inhibition with Secukinumab – Data from a Prospective Open Label Study
Eleni Kampylafka¹, Isabelle Oliveira¹, Christina Linz², Veronika Lerchen¹, Matthias Englbrecht¹, David Simon³, Michael Sticherling⁴, Juergen Rech⁵, Arnd Kleyer³, Georg Schett⁶ and Axel J. Hueber³, ¹Department of Internal Medicine 3 – Rheumatology and Immunology, Friedrich-Alexander-University Erlangen-Nürnberg, Erlangen, Germany, ²Department of Internal Medicine 3 – Rheumatology and Immunology, Friedrich-Alexander-University Erlangen-Nürnberg, e, Germany, ³Department of Internal Medicine 3—Rheumatology and Immunology, Friedrich-Alexander-University Erlangen–Nürnberg (FAU), Universitätsklinikum Erlangen, Erlangen, Germany, Erlangen, Germany, ⁴Department of Dermatology, Friedrich-Alexander-University Erlangen-Nürnberg, Erlangen, Germany, ⁵Universitätsklinikum Erlangen, Erlangen, Germany, ⁶Department of Internal Medicine 3, Rheumatology and Immunology, Universitätsklinikum Erlangen, Erlangen, Germany
Background/Purpose: Musculoskeletal changes precede the onset of psoriatic arthritis (PsA). A subset of psoriasis patients is characterized by arthralgia as well as inflammatory changes in…
Abstract Number: 653 • 2018 ACR/ARHP Annual Meeting
Validation of Assessments in Spondyloarthritis International Society MRI Lesion Definitions in Axial Spondyloarthritis: Data from the Echography in Spondyloarthritis Cohort
Walter P. Maksymowych^1,2, Damien Loeuille³, Stephanie Wichuk⁴, Joel Paschke⁵, Olivia Judet⁶, Maxime Breban³, Maria-Antonietta D'Agostino⁷ and Robert G. Lambert⁸, ¹University of Alberta, Edmonton, AB, Canada, ²CaRE Arthritis, Edmonton, AB, Canada, ³Ambroise Paré Hospital, Boulogne-Billancourt, France, ⁴Medicine, Medicine, University of Alberta, Edmonton, AB, Canada, ⁵CaRE Arthritis, Edmonton, Canada, Edmonton, AB, Canada, ⁶CHRU Vandoeuvre les Nancy, Vandœuvre-lès-Nancy, France, ⁷CHRU Vandoeuvre les Nancy, Vandoeuvre les Nancy, France, ⁸Radiology, Radiology, University of Alberta, Edmonton, AB, Canada
Background/Purpose: The diversity of MRI lesions in the sacroiliac joints of patients with axial spondyloarthritis (axSpA) has only recently been appreciated and consistent terminology, descriptions,…
Abstract Number: 654 • 2018 ACR/ARHP Annual Meeting
MRI Lesion Definitions in Axial Spondyloarthritis: A Consensus Reappraisal from the Assessments in Spondyloarthritis International Society
Walter P. Maksymowych¹, Robert G. Lambert², Mikkel Østergaard³, Manouk de Hooge⁴, Susanne J Pedersen³, Alexander N Bennett⁵, Rubén Burgos-Vargas⁶, Iris Eshed⁷, Robert B.M. Landewé⁸, Pedro Machado⁹, Helena Marzo-Ortega¹⁰, Kay-Geert Hermann¹¹, Denis Poddubnyy¹¹, Martin Rudwaleit¹¹, Joachim Sieper¹², Désirée van der Heijde¹³, Irene van der Horst-Bruinsma¹⁴, Ulrich Weber¹⁵ and Xenofon Baraliakos¹⁶, ¹University of Alberta, Edmonton, AB, Canada, ²University of Alberta, Edmonton, AB, Cameroon, ³COPECARE University of Copenhagen, Copenhagen, Denmark, ⁴Ghent University Hospital, Ghent, Belgium, ⁵Rheumatology, Imperial College, London, United Kingdom, ⁶Universidad Nacional Autonoma de Mexico, Mexico City, Mexico, ⁷Radiology, Sheba Medical Center, Tel Aviv, Israel, ⁸Academic Medical Center Amsterdam, Amsterdam, Netherlands, ⁹University College London, London, United Kingdom, ¹⁰University of Leeds, Leeds, United Kingdom, ¹¹Charité Universitätsmeidzin Berlin, Berlin, Germany, ¹²Rheumatology, Charité Universitätsmeidzin Berlin, Berlin, Germany, ¹³Rheumatology, Leiden University Medical Ctr, Leiden, Netherlands, ¹⁴Rheumatology, VU University Medical Center, Amsterdam, Netherlands, ¹⁵University of Southern Denmark, Odense, Denmark, ¹⁶Rheumazentrum Ruhrgebiet Herne, Herne, Germany
Background/Purpose: There has been substantial progress in the characterization of MRI lesions in the sacroiliac joints (SIJ) and spine in axial spondyloarthritis (axSpA) since the…
Abstract Number: 655 • 2018 ACR/ARHP Annual Meeting
Diagnostic Performance of MRI Lesions in the Sacroiliac Joints According to Updated Assessments in Spondyloarthritis International Society Lesion Definitions: A Central Reader Assessment of MRI Scans from the Assessments in Spondyloarthritis Classification Cohort
Walter P. Maksymowych^1,2, Xenofon Baraliakos³, Robert G. Lambert⁴, Pedro Machado⁵, Joachim Sieper⁶, Stephanie Wichuk⁷, Denis Poddubnyy⁶, Susanne J Pedersen⁸, Joel Paschke², Mikkel Østergaard⁸ and Ulrich Weber⁹, ¹Medicine, University of Alberta, Edmonton, AB, Canada, ²CaRE Arthritis, Edmonton, AB, Canada, ³Rheumazentrum Ruhrgebiet Herne, Herne, Germany, ⁴Radiology, Radiology, University of Alberta, Edmonton, AB, Canada, ⁵University College London, London, United Kingdom, ⁶Charité Universitätsmeidzin Berlin, Berlin, Germany, ⁷Medicine, Medicine, University of Alberta, Edmonton, AB, Canada, ⁸COPECARE University of Copenhagen, Copenhagen, Denmark, ⁹University of Southern Denmark, Odense, Denmark
Background/Purpose: The ASAS MRI group has generated updated consensus lesion definitions (ASAS_MRI_defn) for the spectrum of MRI lesions in the SIJ. Their relative performance as…
Abstract Number: 656 • 2018 ACR/ARHP Annual Meeting
What Is the Level of Agreement between Local and Central Readers in the Detection of Active and Structural MRI Lesions Typical of Axial Spondyloarthritis? Data from the Assessments in Spondyloarthritis Classification Cohort Study
Walter P. Maksymowych^1,2, Xenofon Baraliakos³, Robert G. Lambert⁴, Ulrich Weber⁵, Joachim Sieper⁶, Stephanie Wichuk¹, Denis Poddubnyy⁷, Mikkel Østergaard⁸, Joel Paschke², Susanne J Pedersen⁸ and Pedro Machado⁹, ¹Medicine, Medicine, University of Alberta, Edmonton, AB, Canada, ²CaRE Arthritis, Edmonton, AB, Canada, ³Rheumazentrum Ruhrgebiet Herne, Herne, Germany, ⁴Radiology, Radiology, University of Alberta, Edmonton, AB, Canada, ⁵University of Southern Denmark, Odense, Denmark, ⁶Charité Universitätsmeidzin Berlin, Berlin, Germany, ⁷Rheumatology, Charité Universitätsmeidzin Berlin, Berlin, Germany, ⁸COPECARE University of Copenhagen, Copenhagen, Denmark, ⁹University College London, London, United Kingdom
Background/Purpose: There has been no central reader evaluation of MRI scans from the ASAS Classification Cohort (ASAS-CC)1 to compare detection of lesions between central and…
Abstract Number: 657 • 2018 ACR/ARHP Annual Meeting
First Validation of Consensus Definitions for MRI Lesions in the Sacroiliac Joint By the Assessments in Spondyloarthritis International Society MRI Group
Walter P. Maksymowych^1,2, Ulrich Weber³, Susanne J Pedersen⁴, Xenofon Baraliakos⁵, Pedro Machado⁶, Joachim Sieper⁷, Denis Poddubnyy⁷, Stephanie Wichuk¹, Joel Paschke², Robert G. Lambert¹ and Mikkel Østergaard⁴, ¹University of Alberta, Edmonton, AB, Canada, ²CaRE Arthritis, Edmonton, AB, Canada, ³University of Southern Denmark, Odense, Denmark, ⁴COPECARE University of Copenhagen, Copenhagen, Denmark, ⁵Rheumazentrum Ruhrgebiet Herne, Herne, Germany, ⁶University College London, London, United Kingdom, ⁷Charité Universitätsmeidzin Berlin, Berlin, Germany
Background/Purpose: The diversity of MRI lesions in the sacroiliac joints of patients with axial spondyloarthritis (axSpA) has only recently been appreciated and consistent terminology, descriptions,…
Abstract Number: 658 • 2018 ACR/ARHP Annual Meeting
Construct Validation of the Screening for Inflammatory Pain in the Lower Back Questionnaire: Data from the Screening in Axial Spondyloarthritis in Psoriasis, Iritis, and Colitis Cohort
Walter P. Maksymowych^1,2, Raj Carmona³, Jonathan Chan⁴, James Yeung⁵, Sibel Zehra Aydın⁶, Dianne P. Mosher⁷, Ariel Masetto⁸, Liam Martin⁹, Olga Ziouzina⁹, Stephanie Keeling¹⁰, Sherry Rohekar¹¹, Joel Paschke¹², Amanda Carapellucci¹ and Robert G. Lambert¹³, ¹CaRE Arthritis, Edmonton, AB, Canada, ²University of Alberta, Edmonton, AB, Canada, ³St. Joseph's Health Care, Hamilton, ON, Canada, ⁴Artus Health Clinic, Vancouver, BC, Canada, ⁵James Yeung Rheumatology, Richmond, BC, Canada, ⁶Ottawa Hospital, Ottawa, ON, Canada, ⁷Med, University of Calgary, Calgary, AB, Canada, ⁸Centre Hospitalier Universitaire de Sherbrooke (CHUS), Faculté de médecine et des sciences de la santé, Université de Sherbrooke, Sherbrooke, AB, Canada, ⁹University of Calgary, Calgary, AB, Canada, ¹⁰Department of Medicine, University of Alberta, University of Alberta, Edmonton, AB, Canada, ¹¹Western University, London, ON, Canada, ¹²CaRE Arthritis, Edmonton, Canada, Edmonton, AB, Canada, ¹³Radiology, Radiology, University of Alberta, Edmonton, AB, Canada
Background/Purpose: The 10-item SIMPLE screening questionnaire for axSpA is a patient self-report standardized questionnaire developed by rheumatologists from the Spondyloarthritis Research Consortium of Canada and…
Abstract Number: 659 • 2018 ACR/ARHP Annual Meeting
Comparison of MRI and Conventional Radiography for Detection of Structural Changes Typical for Spa – Data from the Assessment of Spondyloarthritis International Society Cohort
Mikhail Protopopov¹, Denis Poddubnyy^2,3, Fabian Proft¹, Stephanie Wichuk⁴, Pedro Machado⁵, Robert G. Lambert⁶, Ulrich Weber^7,8, Susanne J Pedersen^9,10, Mikkel Østergaard^9,10, Joachim Sieper³, Martin Rudwaleit^3,11, Xenofon Baraliakos¹² and Walter P. Maksymowych¹³, ¹Charité Universitätsmedizin Berlin, Berlin, Germany, ²German Rheumatism Research Centre, Berlin, Germany, ³Charité Universitätsmeidzin Berlin, Berlin, Germany, ⁴Medicine, Medicine, University of Alberta, Edmonton, AB, Canada, ⁵Centre for Rheumatology Research & MRC Centre for Neuromuscular Diseases, University College London, London, United Kingdom, ⁶Radiology, Radiology, University of Alberta, Edmonton, AB, Canada, ⁷University of Southern Denmark, Odense, Denmark, ⁸Rheumatology, King Christian 10th Hospital for Rheumatic Diseases, Graasten, Denmark, ⁹Copenhagen Center for Arthritis Research, Glostrup Hospital, University of Copenhagen, Copenhagen, Denmark, ¹⁰Department of Clinical Medicine, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark, ¹¹Internal Medicine and Rheumatology, Klinikum Bielefeld Rosenhöhe, Bielefeld, Germany, ¹²Rheumatology, Rheumazentrum Ruhrgebiet, Herne, and Ruhr University Bochum, Herne, Germany, ¹³University of Alberta, Edmonton, AB, Canada
Background/Purpose: The objective of the study was to compare magnetic resonance imaging (MRI) and conventional radiography of the sacroiliac joints (SIJs) for detection of structural…
Abstract Number: 660 • 2018 ACR/ARHP Annual Meeting
Progression of Radiographic Sacroiliitis in Patients with Axial Spondyloarthritis from the Assessment of Spondyloarthritis International Society Cohort on Central Reading – Five-Year Data
Mikhail Protopopov¹, Fabian Proft¹, Alexandre Sepriano^2,3, Robert B.M. Landewé^4,5, Désirée van der Heijde², Joachim Sieper¹, Martin Rudwaleit^6,7 and Denis Poddubnyy^1,8, ¹Charité Universitätsmedizin Berlin, Berlin, Germany, ²Leiden University Medical Center, Leiden, Netherlands, ³Rheumatology, NOVA Medical School, Universidade Nova de Lisboa, Lisbon, Portugal, ⁴Zuyderland Medical Center, Heerlen, Netherlands, ⁵Amsterdam Rheumatology & Clinical Immunology Center, Amsterdam, Netherlands, ⁶Charité Universitätsmeidzin Berlin, Berlin, Germany, ⁷Rheumatology, Klinikum Bielefeld Rosenhöhe, Berlin, Germany, ⁸German Rheumatism Research Centre, Berlin, Germany
Background/Purpose: It is known that radiographic progression of sacroiliitis in axial spondyloarthritis (axSpA) is quite slow, with only few predictors of such progression identified. An…
Abstract Number: 661 • 2018 ACR/ARHP Annual Meeting
Bridging the Gap between Symptom Onset and Diagnosis in Axial Spondyloarthritis
Laura Passalent^1,2,3, Kala Sundararajan⁴, Anthony V. Perruccio⁵, Christopher Hawke^6,7, Nigil Haroon^8,9,10, Robert D Inman^3,11,12 and Y. Raja Rampersaud^5,6,13, ¹Rheumatology, Toronto Western Hospital, Toronto, ON, Canada, Toronto, ON, Canada, ²Department of Physical Therapy, University of Toronto, Toronto, ON, Canada, Toronto, ON, Canada, ³Arthritis Program, Krembil Research Institute, Toronto, ON, Canada, ⁴Orthopaedic Research Department, Toronto Western Hospital, Toronto, ON, Canada, ⁵Arthritis Program, Krembil Research Institute, University Health Network, Toronto, ON, Canada, ⁶Orthopaedics, Toronto Western Hospital, Toronto, ON, Canada, ⁷Department of Physical Therapy, University of Toronto, Toronto, ON, Canada, ⁸Arthrits Program, Krembil Research Institute, Toronto, ON, Canada, ⁹Rheumatology, Toronto Western Hospital, Toronto, ON, Canada, ¹⁰Medicine, Rheumatology, University of Toronto, Toronto, ON, Canada, ¹¹Department of Medicine, University of Toronto, Toronto, ON, Canada, ¹²Toronto Western Hospital, Toronto, ON, Canada, ¹³University of Toronto, Toronto, ON, Canada
Background/Purpose: Axial spondyloarthritis (axSpA) is diagnosed an average of 9 years after symptom onset (1), partly because inflammatory back pain (IBP) can be difficult…
Abstract Number: 662 • 2018 ACR/ARHP Annual Meeting
Radiographic Progression of Structural Joint Damage in Patients with Active Psoriatic Arthritis Treated with Ixekizumab for up to 3 Years
Désirée van der Heijde¹, Vinod Chandran², Roy Fleischmann³, Olivier Benichou⁴, Suchitrita Rathmann⁴ and Catherine Shuler⁴, ¹Leiden University Medical Centre, Leiden, Netherlands, ²Krembil Research Institute & University of Toronto, Toronto, ON, Canada, ³University of Texas Southwestern Medical Center, Dallas, TX, ⁴Eli Lilly and Company, Indianapolis, IN
Background/Purpose: Ixekizumab (IXE), an IL-17A antagonist, was shown to be superior to placebo (PBO) in inhibiting the progression of structural joint damage in patients (pts)…
Abstract Number: 663 • 2018 ACR/ARHP Annual Meeting
Relative Contributions of Improvements in the Psoriasis Area and Severity Index (PASI) and Disease Activity Index for Psoriatic Arthritis (DAPSA) to Improvements in Quality of Life and Function in Patients with Psoriatic Arthritis
Alexis Ogdie¹, Prashanth Sunkureddi², Baojin Zhu³, Aubrey Spraberry⁴, William Malatestinic⁴, Yan Dong⁴ and David Shrom³, ¹University of Pennsylvania, Philadelphia, PA, ²Rheumatology, Clear Lake Rheumatology Center, Nassau Bay, TX, ³LRL, Eli Lilly and Company, Indianapolis, IN, ⁴Eli Lilly and Company, Indianapolis, IN
Background/Purpose: Psoriatic arthritis (PsA) is a heterogeneous inflammatory condition characterized by the clinical domains of arthritis, enthesitis, dactylitis, spondylitis, and psoriasis. While it is known…
Abstract Number: 664 • 2018 ACR/ARHP Annual Meeting
Prevalence and Factors Associated with Peripheral Manifestations in Spondyloarthritis. an Ancillary Analysis of the ASAS-Comospa Study
Clementina López-Medina¹, Anna Molto² and Maxime Dougados³, ¹Rheumatology Department, Cochin Hospital, Paris, France, ²Hôpital Cochin, Department of Rheumatology, Paris Descartes University, Paris, France, ³Department of Rheumatology, Paris Descartes University and Cochin Hospital, Paris, France
Background/Purpose: Peripheral manifestations (arthritis, enthesitis and dactylitis) can be observed in patients with Spondyloarthritis (SpA), but the factors associated with their presence are not well…
Abstract Number: 665 • 2018 ACR/ARHP Annual Meeting
Impact of Peripheral Manifestations on Patient-Reported Outcomes (PROs) and Treatment in Spondyloarthritis. Data from ASAS-Comospa
Clementina López-Medina¹, Anna Molto² and Maxime Dougados³, ¹Rheumatology Department, Cochin Hospital, Paris, France, ²Hôpital Cochin, Department of Rheumatology, Paris Descartes University, Paris, France, ³Department of Rheumatology, Paris Descartes University and Cochin Hospital, Paris, France
Background/Purpose: Peripheral manifestations (arthritis, enthesitis and dactylitis) are frequent in patients with Spondyloarthritis (SpA). However, little is known regarding the impact of these manifestations on…

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].